Recommendations on screening for prostate cancer with the prostate-specific antigen test. - Wikidata - wikimedia - TriplyDB

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

http://www.wikidata.org/entity/Q34435885

about

Adult health checkup: Update on the Preventive Care Checklist Form©Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review A primer on tumour immunology and prostate cancer immunotherapy Active surveillance and focal therapy for low-intermediate risk prostate cancer The community pharmacist's role in cancer screening and prevention Prostate cancer in Brazil and Latin America: epidemiology and screening Better decision making in preventive health screening: Balancing benefits and harms.Prendre de meilleures décisions en matière de dépistage préventif: Équilibrer bienfaits et préjudices.Highlights of the university of toronto urology update 2014.Eliciting women's cervical screening preferences: a mixed methods systematic review protocol Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study.What do urologists think patients need to know when starting on androgen deprivation therapy? The perspective from Canada versus countries with lower gross domestic product.Association of Material Deprivation Status, Access to Health Care Services, and Lifestyle With Screening and Prevention of Disease, Montreal, Canada, 2012.Trends in prostate biopsy in Ontario, 1992-2014: a cohort study.Choosing Wisely: The Canadian Society of Nephrology's List of 5 Items Physicians and Patients Should Question.Multigene panels in prostate cancer risk assessment: a systematic review.What's new in screening in 2015?VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man.Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms.Active surveillance in Canadian men with low-grade prostate cancer.Consistency and sources of divergence in recommendations on screening with questionnaires for presently experienced health problems or symptoms: a comparison of recommendations from the Canadian Task Force on Preventive Health Care, UK National Scre Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions.Implications of prostate-specific antigen screening guidelines on clinical practice at a Canadian regional community hospital Prostate cancer screening: going beyond the clinical evidence In 2124, half of all men can count on developing prostate cancer.Making our voices heard.PSA screening: And now…a message from our experts The utility of provincial AS guidelines.Outils d’application des connaissances en soins de santé préventifs.Recommandations de l’Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer.Men's perspectives of prostate cancer screening: A systematic review of qualitative studies.Personal prostate-specific antigen screening and treatment choices for localized prostate cancer among expert physicians.Prevalence and associations of general practitioners' ordering of "non-symptomatic" prostate-specific antigen tests: A cross-sectional analysis.Prostate cancer screening among family physicians in Ontario: An update on attitudes and current practice.Quantification of large scale DNA organization for predicting prostate cancer recurrence.Knowledge translation tools in preventive health care.Perspective on Cancer Therapeutics Utilizing Analysis of Circulating Tumor Cells.Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis.Choisir les guides de pratique clinique à utiliser.

P2860

Q26748616-EEDB472C-EF56-43AA-A154-AE5AAF624CEE Q26748873-C2CA58F4-BAEF-405B-97A6-6EE1B693038A Q26765697-82C36337-42D7-4BC4-BA54-FFB6B3D1DBAE Q26773641-29D62E08-51C7-40F5-9A5A-E15A393C4352 Q28074284-218A4D88-0197-487A-AA34-875992A626E7 Q28079012-479E47A7-7F0F-4F22-B8A6-3ED97A00408F Q33897609-EB0022B4-3FE5-44B7-8D7F-08BA4CC30844 Q33897614-121A698D-5E86-4C7B-B555-CE577CD377CA Q35100023-9C0ABC5A-E3DE-46D5-BD91-9C81D1A20C99 Q36102272-43361187-0070-47D5-990B-F3A70E885A57 Q36246097-2A1B2280-AD3C-49E4-AD90-6674ED09B5EF Q36814686-D1B7AAAC-7EA3-4816-A49A-8A02A1C33F53 Q37299968-94CE9FF6-4381-4D2A-A711-2302AFC7BFB4 Q37521017-F825351D-8B38-490B-8B3A-98C528332239 Q37695746-0742D1D9-27A5-47BA-887D-64DCF65DD1EE Q38596777-D3B2DC4E-4110-4452-8985-87AE2919CEAE Q38871819-F9A0FBD3-761B-45CC-A5B3-20FEAC09C5BC Q38948710-F4782785-8A12-464E-9F33-59699061B596 Q39289771-EB1E325B-E04C-4CEE-8C0C-879C1E23C7D6 Q39958888-40DA9D59-41CD-43B7-8A2B-51EA6D7B7A25 Q40090385-B6268835-5A09-468E-AE5C-A39F68EFACC9 Q41109068-DE9D0471-5EE4-4E30-90CE-2B7DC810D6DA Q41240464-B7F0AD65-9AD5-45C2-AD5B-E6B830B46CEE Q41896134-2F9F8A1D-16E7-4A82-B362-E68DE031CED7 Q41898131-3EDD3C7D-7962-4127-96D1-4399E06F45F3 Q42003041-24E1D9D0-6973-4C53-AC1E-7703DB9B5979 Q42110492-2BBB61E9-2037-4D94-9746-93A9ED388374 Q42408017-D06B8DAF-BAA6-4E51-97E7-DDAB567EA948 Q45735323-0910ECC6-4255-4E5D-8F2A-59EA4C328A54 Q47123251-2F575F6C-AB8E-4849-B4E6-40B4D2645542 Q47125420-5C08C34E-F4EE-484D-B2CE-51D5189481E3 Q47188433-B95F2A2C-B146-4DD2-A8F6-3B5DB7E15E54 Q47548118-D2D87752-2DE2-406C-8302-777AA8F26A9E Q48133169-027B0BDD-3E7D-4472-9DF8-9A21FD3CF569 Q48502418-54E78BA7-9FDF-4D7C-9ED7-E103CC066FA1 Q48516686-F415E9F0-67C9-4712-BD7F-831FF15B20AC Q49489086-FC3974A7-00D3-484E-9D5C-9BFE8568DD15 Q52594191-551AE8D3-B90B-4835-99E4-BF3BE10E8898 Q53274562-6768404B-A324-4E6A-85EE-F3FCFB0F8CE2 Q53818908-912162C8-2640-492E-9592-F75152B10F8E

P2860

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

http://www.wikidata.org/entity/Q34435885

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@ast

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@en

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@nl

type

label

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@ast

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@en

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@nl

prefLabel

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@ast

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@en

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@nl

P1433

Q34435885-49F03843-665D-423A-B660-4035F31881EE

P1476

Q34435885-751D0A9E-BD50-4D12-A655-FD5FF298C5BC

P2093

Q34435885-2522EFAD-9F88-4045-836D-19F9C346BAC4

Q34435885-2F51D9CF-B0BF-44D6-9FCC-6E3DF055380D

Q34435885-47C808E2-B48E-42B1-BC81-354B62A065FF

Q34435885-76375536-5273-4F38-BE17-1C69ED52F6C0

Q34435885-ABE91468-F3B9-4120-9D53-66CA21A4DB8C

Q34435885-BF6968B8-F53F-41B2-9201-6394868C4FF9

Q34435885-CE501DA7-0EE6-448D-9C2D-030484989DAF

Q34435885-F7CF4459-0D19-4921-B4C1-6C2C06D098A5

Q34435885-FE74C391-6DE9-42CE-9A63-001F2DC87FE1

P2860

Q34435885-01F58C75-51EB-4AFB-B84A-3F8A75BC352C

Q34435885-0282EFD3-6D75-4428-8678-5F7F507680FA

Q34435885-037F4865-071D-493A-BCB8-66C37C3BFC04

Q34435885-03D5684F-515E-41D7-AEC7-FF1A4F63E418

Q34435885-0933F53C-42A0-406D-BC1C-FE7F42452B2E

Q34435885-098E3F22-664B-4FA9-96AF-E93396929AB2

Q34435885-148B607D-C97F-46E7-AE4C-21AC325EF88F

Q34435885-222E920D-C9EF-4BFC-ABDB-AD1F40AEA106

Q34435885-223DFCBE-17A0-4726-A489-59448C7A2397

Q34435885-326DEF4F-475D-4DC2-B30C-0EFEDE97208E

P304

Q34435885-28674AA6-4EE5-4C3E-BB7D-8AE9EC9007DA

P31

Q34435885-622D03F3-5E7D-4C2E-A0F2-8E5B68B54834

P356

Q34435885-74BC326C-FE09-46EB-91B3-B5623E1ED8AB

P407

Q34435885-832CCC60-3434-4A95-9702-4CF639E5AEB2

P433

Q34435885-3C6BDBE5-6C3C-4114-B369-439DFEB6C4D4

P478

Q34435885-28C9DD91-6950-4B2B-8083-3D969561FCFC

P50

Q34435885-3571AC96-FE0E-4D8F-84C2-BF29251807DC

P577

Q34435885-DF84A914-AE06-4299-878C-6959807F14FC

P698

Q34435885-E7AA6035-26D0-429A-88C9-B4E0B124BCEB

P932

Q34435885-5663BC6D-83AE-4C95-929B-C9C021BFB0F6

P356

P1433

Canadian Medical Association Journal

P1476

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

@en

P2093

Amanda Shane

http://www.w3.org/2001/XMLSchema#string

Canadian Task Force on Preventive Health Care

http://www.w3.org/2001/XMLSchema#string

Elizabeth Shaw

http://www.w3.org/2001/XMLSchema#string

Harminder Singh

http://www.w3.org/2001/XMLSchema#string

James Dickinson

http://www.w3.org/2001/XMLSchema#string

Lesley Dunfield

http://www.w3.org/2001/XMLSchema#string

Michel Joffres

http://www.w3.org/2001/XMLSchema#string

Neil Bell

http://www.w3.org/2001/XMLSchema#string

Sarah Connor Gorber

http://www.w3.org/2001/XMLSchema#string

P2860

Cumulative incidence of false-positive results in repeated, multimodal cancer screening

Randomised prostate cancer screening trial: 20 year follow-up

Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Overdiagnosis in cancer.

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.

P304

1225-1234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.140703

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P50

Marcello Tonelli

P577

2014-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25349003

http://www.w3.org/2001/XMLSchema#string

P932

4216256

http://www.w3.org/2001/XMLSchema#string